As depicted in Figure 5h,i, the tumor sections from the DMXAA treatment group exhibited a discontinuous distribution of red fluorescent CD31 staining, indicating significant disruption of tumor vascular integrity. The gene discussed is PECAM1; the disease is neoplasm.